The peptide industry, which offers various health and cosmetic benefits, is experiencing significant growth, largely funded by cryptocurrency. A report from Chainalysis indicates that this gray market is now valued at over $100 million annually, with some Chinese labs transitioning from fentanyl precursor production to peptide manufacturing to capitalize on social media trends and avoid legal scrutiny.
This shift highlights the unregulated nature of the peptide market and raises concerns about the potential risks associated with these substances. As the demand for peptides increases, particularly among those seeking aesthetic improvements, the implications for public health and safety may become more pronounced.